视网膜保护新型营养药物配方的视网膜保护
Luca Rosario La Rosa1, Veronica Pepe1, Francesca Lazzara2
1Innovation and Medical Science, SIFI S.p.A., 95025 Aci Sant'Antonio, Italy.
Pharmaceutics
|January 25, 2025
概括
埃皮科林是一种新的营养药,显示出显著的神经保护,抗氧化和抗炎作用. 这种配方通过保护视网膜质细胞 (RGCs) 提供了一种有前途的潜在治疗青光眼的方法.
科学领域:
- 眼科医生 眼科 眼科
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 青光眼对保护视网膜质细胞 (RGCs) 的治疗有着未满足的需求.
- 营养药正在探索它们在神经退行性疾病中的潜在治疗益处.
- 现有的治疗方法往往侧重于眼内压力,而不是直接保护RGC.
研究的目的:
- 评估一种新型营养药物配方Epicolin的神经保护,抗氧化和抗炎作用.
- 为了比较Epicolin与单个成分和现有市场配方的疗效.
- 评估Epicolin在体外和体内玻璃眼模型中的潜力.
主要方法:
- 使用神经母细胞瘤 (SH-SY5Y) 和穆勒 (MIO-M1) 细胞进行体外研究.
- 评估神经保护对稳定和缺氧诱导的损伤.
- 在DBA/2J光眼小鼠的体内评估使用PERG,免疫染和RT-PCR.
主要成果:
- 埃皮科林在SH-SY5Y细胞中显示出显著的神经保护作用,这归因于成分的协同作用.
- 与对照剂和其他配方相比,Epicolin表现出优越的抗氧化和清除活性.
- 在体内,Epicolin通过调节BDNF,IL-1β和TNF-α来保护RGC免受功能损失和减少细胞死亡.
结论:
- 埃皮科林具有重要的神经保护,抗氧化和抗炎性质.
- 配方的协同作用有助于其有效性.
- 埃皮科林代表了一种有前途的治疗候选者,用于治疗青光眼.
相关概念视频
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
FDA Approved Drugs: Changes to Approved Drugs
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...


